CXCL8 and cancer: Mechanistically, Huaier inhibits interleukin-8 (IL-8) expression through the inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and activator protein-1 (AP-1), thus attenuating cisplatin resistance and cancer stemness both in vitro and in vivo [74].